Retroviral intasome assembly and inhibition of DNA strand transfer
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Integrase is an essential retroviral enzyme that binds both termini of linear viral DNA and inserts them into a host cell chromosome. The structure of full-length retroviral integrase, either separately or in complex with DNA, has been lacking. Furthermore, although clinically useful inhibitors of HIV integrase have been developed, their mechanism of action remains speculative. Here we present a crystal structure of full-length integrase from the prototype foamy virus in complex with its cognate DNA. The structure shows the organization of the retroviral intasome comprising an integrase tetramer tightly associated with a pair of viral DNA ends. All three canonical integrase structural domains are involved in extensive protein-DNA and protein-protein interactions. The binding of strand-transfer inhibitors displaces the reactive viral DNA end from the active site, disarming the viral nucleoprotein complex. Our findings define the structural basis of retroviral DNA integration, and will allow modelling of the HIV-1 intasome to aid in the development of antiretroviral drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The structures revealed unexpected architectural diversity among intasomes from different retroviral genera.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with their function, all intasomes feature 2-fold symmetry and harbour a pair of juxtaposed active sites engaged with 3’ vDNA ends.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Within the CIC, the IN dimers are bridged via the exchange of associated NTDs and are joined by a pair of CTDs (referred to as the synaptic CTDs), which act as rigid spacers.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the intasomes from the prototype foamy virus (PFV, a simiispumavirus) as well as the δ-retroviruses HTLV-1 and simian T-cell lymphotropic virus (STLV) contain four IN subunits (arranged as a dimer-of-dimers)25,29,37,38”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite these differences, all intasomes incorporate the conserved intasome core (CIC) assembly, which is the minimal functional unit and is represented by the PFV structure (Figs. 2A, 3).”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
The interpretation of protein structures: Estimation of static accessibility
Lee, B., & Richards, F. M. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90324-x · Cited by 5,850
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,804
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,896
The Buccaneer software for automated model building. 1. Tracing protein chains
Cowtan, K. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906022116 · Cited by 1,822
Use of TLS parameters to model anisotropic displacements in macromolecular refinement
Winn, M. D., Isupov, M. N., & Murshudov, G. N. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444900014736 · Cited by 1,696
Gouet, P. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg556 · Cited by 1,509
Research works printed but not linked: 2
- Grobler, J. A., Stillmock, K., Miller, M. D. & Hazuda, D. J. Mechanism by which the HIV integrase active-site mutation N155H confers resistance to raltegravir. Antivir. Ther. 13 (suppl. 3). A41 (2008)
- Leslie, A. G. W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 and ESF-EAMCB Newsletter on Protein Crystallography no. 26, (1992)
Cited by
Items 501–600 of 719
Thierry, E., Lebourgeois, S., Simon, F., Delelis, O., & Deprez, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-14564-w · Cited by 5
Naz, Z., Moin, S. T., & Hofer, T. S. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b07639 · Cited by 5
Ty3, a Position-specific Retrotransposon in Budding Yeast
Sandmeyer, S. B., Patterson, K., & Bilanchone, V. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch42 · Cited by 6
C-Terminal Domain of Integrase Binds between the Two Active Sites
Roberts, V. A. (2015) · Journal of Chemical Theory and Computation · doi:10.1021/ct501125r · Cited by 6
Feyssa, M. D. (2015) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000465 · Cited by 5
“Recently X-ray diffraction data were obtained for the structure of integrase in combination with the viral DNA [20].”
BackgroundErcan, S. (2016) · Journal of the Turkish Chemical Society Section A Chemistry · doi:10.18596/jotcsa.287327 · Cited by 5
Structural Studies of Retroviral Integrases
Jaskólski, M., Alexandratos, J. N., Bujacz, G., & Wlodawer, A. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch4 · Cited by 5
Park, J. H., Shi, Y., Han, J., Li, X., Kim, T. H., & Yun, J. H. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6jcg/pdb · Cited by 5
DNA Polymerases: Reverse Transcriptase Integrase, and Retrovirus Replication
Andréola, M., Parissi, V., & Litvak, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378630-2.00258-9 · Cited by 5
Lotfaliei, M., Rezaee, E., Hajimahdi, Z., Rabbani, M. M., Zabihollahi, R., Aghasadeghi, M. R., & Tabatabai, S. A. (2021) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr.123827 · Cited by 4
Montermoso, S., Eilers, G., Allen, A., Sharp, R., Hwang, Y., Bushman, F. D., Gupta, K., & Duyne, G. D. V. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169224 · Cited by 5
“We previously proposed a favored model [16] ascribing this effect to the predicted clash of the favored proximal docking of the NTD against the CCD observed in many experimental structures [25,39,45,51,52] with the observed drug-stabilized CCD-CTD interface (Supplemental Figure 2).”
Machado, L. D. A., & Guimarães, A. C. R. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00170 · Cited by 8
Twelfth International Foamy Virus Conference—Meeting Report
Herchenröder, O., Löchelt, M., Buseyne, F., Antoine Gessain, A., Soares, M. A., Khan, A. S., & Lindemann, D. (2019) · Viruses · doi:10.3390/v11020134 · Cited by 4
“Arifa Khan (U.S. Food and Drug Administration, Silver Spring, MD, USA) presented the careful characterization of SFV-infected human A549 cell clones with various viral expression patterns, defined by viral DNA and RNA expression and production of infectious virions.”
BackgroundInfluentialvan Kampen, J. J. A., van Nood, E., Mahmud, R., Krullaars, Z., Voskamp, T. S., Voskamp, M., Nijssen, T., Voermans, J. J. C., Charpentier, C., Hingrat, Q. L., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae705 · Cited by 4
Structural dynamics of native and V260E mutant C-terminal domain of HIV-1 integrase
Balasubramanian, S., Rajagopalan, M., & Ramaswamy, A. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-015-9830-y · Cited by 4
“The recently solved structure of PFV intasome provides clear picture on the organization of IN tetramer during the concerted integration of viral and host DNA [31].”
BackgroundOkello, M. O., Mishra, S., Nishonov, M., Mankowski, M. K., Russell, J. D., Wei, J., Hogan, P. A., Ptak, R. G., & Nair, V. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.04.005 · Cited by 4
“Integration of HIV DNA into the host cell genome requires metal ion cofactors and occurs through several steps including, site-specific endonuclease activity of the integrasebound viral cDNA (30-processing step), transport of the processed intasome complex through the nuclear envelope into the nucleus, integrase-catal…”
BackgroundNucleotides and nucleic acids; oligo- and polynucleotides
Loakes, D. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734875-00169 · Cited by 4
Korolev, S. P., Knyazhanskaya, E. S., Anisenko, A. N., Ташлицкий, В. Н., Zatsepin, T. S., Gottikh, M., & Agapkina, J. (2011) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2011.592890 · Cited by 4
“In the nucleus of the infected cell, IN mediates a strand transfer reaction that inserts the viral DNA into the host DNA.”
BackgroundInfluentialJohns, B. A., Kawasuji, T., & Velthuisen, E. J. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849737814-00149 · Cited by 6
The HIV-1 Integrase: Modeling and Beyond
Arora, R., & Tchertanov, L. (2013) · InTech eBooks · doi:10.5772/52344 · Cited by 5
“This difference may be due to a difference in the sequence of the two enzymes or an effect induced by DNA bind‐ ing, and caution is therefore required in the use of this structure as a template for modelling biologically relevant conformations of HIV-1 IN [2,45].”
BackgroundMethodInfluentialLee, G.-E., Kim, J., & Shin, C. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1530969 · Cited by 4
“many antiretroviral drug studies, FVs are used as a model virus since FV integrase (IN) has been crystallized and studied in detail [6,7].”
Zhang, Z., Yuan, S., Xu, S., Guo, D., Chen, L., Hou, W., & Wang, M. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00311-5 · Cited by 4
Okello, M. O., Mishra, S. K., Nishonov, M., & Nair, V. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.050 · Cited by 4
Structural and Functional Insights into Foamy Viral Integrase
Hossain, M. A., Ali, M. K., & Shin, C. (2013) · Viruses · doi:10.3390/v5071850 · Cited by 6
“Intasome crystals differ in the basic Zn-IN-vDNA assembly and the presence of ligands: Mn or Mg, target DNA, or inhibitors were yielded from the PFV system [25].”
BackgroundInfluentialDayer, M. R. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.29773 · Cited by 4
“Even though the full-length crystal structure of integrase from prototype foamy virus (PFV) in complex with DNA is available to model HIV-1 integrase in bioinformatics methods for drug design, there is an essential need for the full-length coordinate structure of HIV-1 integrase (29-39).”
BackgroundRasila, T. S., Pulkkinen, E., Kiljunen, S., Haapa-Paananen, S. M., Pajunen, M. I., Salminen, A., Paulin, L. G., Vihinen, M., Rice, P. A., & Savilahti, H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1281 · Cited by 7
Jing, T., Shan, Z., Dinh, T., Biswas, A., Jang, S., Greenwood, J., Li, M., Zhang, Z., Gray, G., Shin, H. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.26.577436 · Cited by 4
Self-citationThe role of chromatin in retroviral preintegration complex function
Sapp, N., Prakash, P., Chakraborty, R., Balasubramaniam, M., & Dash, C. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110440 · Cited by 3
“PFV has been a powerful system for studying the integration mechanism with nucleosome substrates (212, 214, 215, 289–293).”
Bidentate Metal-Binding Motifs in US FDA Approved Small Molecule Drugs
Njardarson, J. T., & Tomat, E. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01319 · Cited by 3
Benyamini, H., Loyter, A., & Friedler, A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.116 · Cited by 4
“Alignment of our model with the recently solved FPV tetramer structure [27] does not rule out Rev binding to either the IN dimer or tetramer in terms of steric clash (Fig.”
BackgroundCrosby, D. C., Lei, X., Gibbs, C. G., Reinecke, M. G., & Robinson, W. E. (2015) · Natural Product Communications · doi:10.1177/1934578x1501000129 · Cited by 3
“Compounds 1-7 and 5-CITEP exhibited potency against reference IN consistent with published results (Table 2, [7, 13, 51]).”
BackgroundMethodResultInfluentialOligomerization of Retrovirus Integrases
Grandgenett, D. P., & Aihara, H. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-10-8456-0_10 · Cited by 4
Foamy Virus Integrase in Development of Viral Vector for Gene Therapy
Kim, J., Lee, G., & Shin, C. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2003.03046 · Cited by 3
“In 2010, the crystal structure of the 3'-end-processed PFV synaptic complex provided the first observation of any retroviral intasome [59].”
BackgroundInfluentialDNA strand breaks and gaps target retroviral intasome binding and integration
Senavirathne, G., London, J. A., Gardner, A., Fishel, R. A., & Yoder, K. E. (2023) · Nature Communications · doi:10.1038/s41467-023-42641-4 · Cited by 4
“Prototype foamy virus (PFV) is a member of the spumavirus subfamily, and its IN has been extensively studied since it shares similar catalytic site geometry, chemistry, and therapeutic inhibitor sensitivity with the pathogenic lentivirus HIV-1 IN 31 – 33 .”
BackgroundInfluentialSayyed, S. K., Quraishi, M., Jobby, R., Rameshkumar, N., Sonawane, T., & Ravichandran, V. (2024) · ChemistrySelect · doi:10.1002/slct.202403809 · Cited by 3
Structural studies of the catalytic core of the primate foamy virus (PFV-1) integrase
Réty, S., Řežábková, L., Dubanchet, B., Šilhán, J., Legrand, P., & Lewit‐Bentley, A. (2010) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309110022852 · Cited by 5
“Indeed, the structure of PFV-1 IN in complex with a DNA oligonucleotide has recently been solved (Hare et al., 2010).”
BackgroundInfluentialPharmacokinetics and dose-range finding toxicity of a novel anti-HIV active integrase inhibitor
Nair, V., Okello, M. O., Mishra, S., Mirsalis, J. C., O’Loughlin, K. G., & Zhong, Y. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.05.001 · Cited by 3
“Integration of HIV DNA into the host genome requires several steps, including the strand transfer of processed viral cDNA ends into host chromosomal DNA (Frankel and Young, 1998; Haren et al., 1999; Hare et al., 2010).”
BackgroundInfluentialTsuruyama, T., NAKAI, T., Ohmori, R., Ozeki, M., Tamaki, K., & Yoshikawa, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053572 · Cited by 3
“recently reported a crystal structure of prototype foamy virus integrase complexed with its cognate DNA [1] that is suggestive of a tetrameric structure.”
BackgroundThe Road to HIV-1 Integrase Inhibitors: The Case for Supporting Basic Research
Craigie, R. (2014) · Future Virology · doi:10.2217/fvl.14.77 · Cited by 3
Levita, J., & Chao, K. H. (2014) · Cited by 3
The Preserved HTH-Docking Cleft of HIV-1 Integrase Is Functionally Critical
Galilee, M., Britan‐Rosich, E., Griner, S. L., Uysal, S., Baumgärtel, V., Lamb, D. C., Kossiakoff, A. A., Kotler, M., Stroud, R. M., Marx, A., et al. (2016) · Structure · doi:10.1016/j.str.2016.08.015 · Cited by 4
“The fundamental role of CCD helix α-4 in viral DNA recognition, binding and catalysis has been intensively investigated and is well established (reviewed in (Azzi et al., 2010; Hare et al., 2010)).”
BackgroundCiubotaru, M., Musat, M. G., Surleac, M. D., Ionita, E., Petrescu, A., Abele, E., & Abele, R. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180406114405 · Cited by 3
Retroviral DNA Transposition: Themes and Variations
Skalka, A. M. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch48 · Cited by 3
Khoury, L. E., Hage, K. E., Piquemal, J., Fermandjian, S., Maroun, R. G., Gresh, N., & Hobaika, Z. (2019) · PeerJ Physical Chemistry · doi:10.7717/peerj-pchem.6 · Cited by 3
“In the used computational approaches, all complexes were extracted from the X-ray structures of the PFV intasome (IN-viral DNA-Mg) in complex with EVG (Hare et al., 2010a) (PDB code: 3L2U), DTG (Hare et al.”
BackgroundMethodRole of Metals in HIV‐1 Integrase Inhibitor Design
Sechi, M., Carcelli, M., Rogolino, D., & Neamati, N. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch20 · Cited by 6
Liao, C., & Nicklaus, M. C. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch28 · Cited by 3
Craigie, R. (2010) · Nature · doi:10.1038/464167a · Cited by 3
Zhao, X. Z., Li, M., Smith, S. J., Karbasi, A. B., Choudhuri, I., Jing, T., Lyumkis, D., Craigie, R., & Burke, T. R. (2025) · NAR Molecular Medicine · doi:10.1093/narmme/ugaf039 · Cited by 3
Finding, Conducting, and Nurturing Science: A Virologist's Memoir
Skalka, A. M. (2017) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-042011 · Cited by 2
Efficient Nonviral Stable Transgenesis Mediated by Retroviral Integrase
Chiang, C.-Y., Ligunas, G. D., Chin, W., & Ni, C. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.04.020 · Cited by 2
“In contrast to 30 processing, which requires the dimeric form of integrase,(15) it was shown that concerted integration requires at least a tetrameric form of integrase,(16,17) and the structure analysis of intasomes revealed that a higher-order integrase multimer can self-associate into a functional intasome.(18,19)…”
Yu, Y.-Y., Xu, M.-S., Liang, H., Wang, H.-Y., Yu, C., & Liu, Q. (2023) · Polish Journal of Veterinary Sciences · doi:10.24425/pjvs.2023.145019 · Cited by 3
“In EIAV-DNA 3′-end processing, the two nucleotides at the dsDNA 3′ end are removed, mediated by integrase, to form the PIC (Hare et al. 2012).”
BackgroundMolecular determinants for Rous sarcoma virus intasome assemblies involved in retroviral integration
Bera, S., Shi, K., Aihara, H., Grandgenett, D. P., & Pandey, K. K. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104730 · Cited by 2
“Similar to RSV, earlier studies of PFV (13, 31) and MVV (16) intasomes, which are tetrameric and hexadecameric intasomes, respectively, also showed essentially no changes before and after target DNA binding.”
BackgroundMethodResultInfluentialHashimoto, K., Kimura, K., Ishida, K., Morita, E., Tanaka, K., & Hashimoto, M. (2023) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c00353 · Cited by 2
Darazi, P. E., Khoury, L. E., Hage, K. E., Maroun, R. G., Hobaika, Z., Piquemal, J., & Gresh, N. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00440 · Cited by 2
Pharmacophore and docking-based 3D-QSAR studies on HIV-1 integrase inhibitors
Zhang, X., Deng, D., Tan, J., He, Y. H., Li, C., & Wang, C. (2014) · Chemical Research in Chinese Universities · doi:10.1007/s40242-014-3395-5 · Cited by 2
HIV-1 Integrase Strand Transfer Inhibitors
Johns, B. A. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45016-2 · Cited by 2
Charmetant, J., Moreau, K., Gallay, K., Ballandras-Colas, A., Gouet, P., & Ronfort, C. (2011) · Virology · doi:10.1016/j.virol.2011.09.008 · Cited by 2
“Assuming that two-ended concerted integration is carried out by a tetramer (Faure et al., 2005; Hare et al., 2009a, 2009b, 2010; Kotova et al., 2010; Li et al., 2006; Maertens et al., 2003, 2010; Michel et al., 2009), our data could be explained by considering a role of viral DNA in assembling…”
BackgroundInfluentialHenríquez, D. R., Zhao, C., Zheng, H., Arbildua, J. J., Acevedo, M. L., Roth, M. J., & León, Ó. (2013) · BMC Structural Biology · doi:10.1186/1472-6807-13-14 · Cited by 2
“The X-ray structure of a tetrameric integrase complex of the PFV IN and processed U5 DNA was solved [14-16].”
BackgroundMoody, I. S., Verde, S. C., Overstreet, C. M., Robinson, W. E., & Weiss, G. A. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.008 · Cited by 2
Delelis, O., & Deprez, E. (2015) · Reviews in fluorescence · doi:10.1007/978-3-319-24609-3_12 · Cited by 2
Integrase: Um Alvo Terapêutico Importante no Combate à Infecção HIV/AIDS
dos Santos, M. L. A., Albuquerque, M. G., & de Brito, M. A. (2014) · Revista Virtual de Química · doi:10.5935/rvq.v6i4.567 · Cited by 2
Integrase C-terminal residues determine the efficiency of feline foamy viral DNA integration
Kim, J., Lee, G.-E., Löchelt, M., & Shin, C. (2017) · Virology · doi:10.1016/j.virol.2017.10.022 · Cited by 3
Yuldasheva, G. A., Zhidomirov, G. M., & Ilin, A. I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813627-0.00017-x · Cited by 2
Liu, X., Chu, J., Gui, C., Liao, W., Qin, F., Hu, X., Liang, B., Jiang, J., Huang, J., Ning, C., et al. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.98038 · Cited by 2
“So far, three key viral enzymes in HIV-1 replication, including reverse transcriptase (RT) [9], integrase (IN) [10], and protease (PR), are the main targets for the development of anti-HIV-1 drugs [11, 12].”
Brown, A., Yllano, O. B., Arce, L. D., Evangelista, E. A., Esplana, F. A., Catolico, L. H. R., & Pedro, M. C. L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99074 · Cited by 2
Integrase Mechanism and Function
Craigie, R. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch3 · Cited by 2
Conformationally Constrained Tricyclic HIV Integrase Inhibitors
Fardis, M., Jin, H., Chen, X., Tsiang, M., Chen, J., Kim, C., & Wright, M. R. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch16 · Cited by 2
Pedersen, F. S., & Mikkelsen, J. G. (2021) · Wiley eBooks · doi:10.1002/9780470015902.a0029306 · Cited by 3
Barkova, A., Adhya, I., Conesa, C., Asif-Laidin, A., Bonnet, A., Rabut, E., Chagneau, C., Lesage, P., & Acker, J. (2022) · Mobile DNA · doi:10.1186/s13100-022-00284-0 · Cited by 1
“1A), from several retroviruses and revealed a globally conserved organization, with a multimer of INs assembled on cDNA ends [5–8].”
BackgroundHIV Biology: Detailed Insight into Virion Structural Organization and Its Pathogenesis
Agrawal, D., Chand, K., Preethi, L., Bhukya, P. L., & Barman, M. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-4480-0_22 · Cited by 1
Drug interactions in people with HIV treated with antivirals for other viral illnesses
Okoli, A., & Ogbuagu, O. E. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2455401 · Cited by 1
“INSTIs bind to a complex containing integrase called the intasome, a nucleoprotein that mediates HIV DNA insertion into the infected host cell’s chromatin [21,22].”
van Osch, J. A. T., Voermans, J. J. C., Ouzerne, H., Cromme, A. B. H., Azugbene, E., Voskamp, M., Krullaars, Z., Mahmud, R., Overmars, R. J., Górska, A., et al. (2026) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkag033 · Cited by 1
Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy
Charpentier, C., & Weiss, L. (2010) · Infection and Drug Resistance · doi:10.2147/idr.s8673 · Cited by 1
Cotelle, P. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.624272 · Cited by 1
Biomolecular Modeling and Simulation: The Productive Trajectory of a Field
Tamar Schlick, A., & Collepardo‐Guevara, R. (2013) · Cited by 1
Balasubramanian, S., Rajagopalan, M., Bojja, R. S., Skalka, A. M., Andrake, M., & Ramaswamy, A. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1257955 · Cited by 1
Dual Choice for Dual Target Anti-HIV Therapy
Marchand, C. (2012) · Journal of Clinical Research in HIV AIDS and Prevention · doi:10.14302/issn.2324-7339.jcrhap-12-edt.1.1 · Cited by 1
Imani, A., Soleymani, S., Vahabpour, R., Hajimahdi, Z., & Zarghi, A. (2021) · Medicinal Chemistry · doi:10.2174/1573406417666210125141639 · Cited by 2
de Araújo, R. S., & do Nascimento‐Dias, B. L. (2021) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v2i3.134 · Cited by 1
Successes and challenges with retroviral enzymes: aka: Adventures with the Wlodawer laboratory
Skalka, A. M., Andrake, M., & Katz, R. A. (2016) · Postępy Biochemii · doi:10.18388/pb.2016_27 · Cited by 1
“Our discovery of this unsuspected reaching dimer conformation coincided with the publication by Cherepanov and colleagues of the crystal structure of the prototype foamy virus (PFV) integrase in complex with viral DNA [26].”
Retroviral Integrase Structure and DNA Recombination Mechanism
Engelman, A., & Cherepanov, P. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch44 · Cited by 2
Self-citationAuthentic HIV-1 integrase inhibitors for the treatment of HIV-1/AIDS
Liao, C., & Wang, Q. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18611-0.00026-7 · Cited by 4
Lagadec, F., Singh, P. K., Calmels, C., Lapaillerie, D., Lindemann, D., Parissi, V., Cherepanov, P., Engelman, A., & Lesbats, P. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf449 · Cited by 1
“Structural studies of PFV in-tasomes unveiled important mechanisms of retroviral integration and inhibition of integrase (IN) activity by strand transfer inhibitors [ 7 , 8 ].”
Self-citationUpdate on Raltegravir and the Development of New Integrase Strand Transfer Inhibitors
Shamroe, C. L., Bookstaver, P. B., Rokas, K. E. E., & Weissman, S. (2012) · Southern Medical Journal · doi:10.1097/smj.0b013e318258c847 · Cited by 1
“The metal cofactor binding sites at the core structure of integrase inhibitors are thought to play a central role in this interaction.(31,32) Coadministration of calcium therapy with RAL also has been linked to virologic failure.”
BackgroundNakamura, T., Campbell, J. R., Moore, A. R., Otsu, S., Aikawa, H., Tamamura, H., & Mitsuya, H. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.07.023 · Cited by 1
“In 2010, the crystal structure of prototype foamy virus (PFV) intasome in retroviruses was solved with the association of 19 nucleotides of the viral DNA (Hare et al., 2010; Maertens et al., 2010).”
BackgroundYang, Y., Lee, J., Jeong, H., Shim, J., Baek, M., Son, M.-J., Kim, Y., Noh, H., & Lim, K. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27540 · Cited by 1
“I‐TASSER produced the predicted structures of wild‐type and mutant integrases using template structural models including 3L2R, 3L2Q, 3L2S, and 5CZ1 (Ballandras‐Colas et al., 2016; Hare et al., 2010).”
MethodKarimi, N., Vahabpour, R., Movahed, M. A., Hajimahdi, Z., & Zarghi, A. (2021) · Iranian journal of pharmaceutical research · doi:10.22037/ijpr.2020.114341.14803 · Cited by 1
Iamarino, A. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2012.tde-13112012-083943 · Cited by 2
Caracterização biológica e molecular de recombinantes naturais de HIV-1.
de Melo, F. L. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2011.tde-20102011-133503 · Cited by 3
Successes and challenges with retroviral enzymes.
Skalka, A. M., Andrake, M., & Katz, R. A. (2016) · PubMed · Cited by 1
Vesiculovirus G protein-based stable cell lines for continuous lentiviral vector production
Tijani, M. (2018) · UCL Discovery (University College London) · Cited by 1
The mouse mammary tumor virus intasome exhibits distinct dynamics on target DNAPreprint
Baltierra‐Jasso, L. E., Jones, N. D., Ballandras-Colas, A., Engelman, A., Fishel, R. A., & Yoder, K. E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.17.468995 · Cited by 1
“Recombinant MMTV intasomes were assembled with Cy5 labeled vDNA (8,9,13,15,17).”
BackgroundMethodInfluentialSelf-citationRegression QSAR Models for Predicting HIV-1 Integrase InhibitorsPreprint
Xuan, C. H. H., Lee, N. K., Rahman, T., Hwang, S. S., Yam, W. K., & Wezen, X. C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.23.432583 · Cited by 1
“These two interactions are important for the stabilization of raltegravir in the active site.(43) The protein-inhibitor interaction diagrams are in Supplementary Figure S5-S7”
BackgroundFunk, M. (2018) · theses.fr (ABES) · doi:10.70675/0303ae66zace8z4f41zbc60zf747fb33a4aa · Cited by 2
Biochemical, Structural, And Drug Design Studies Of Multi-Drug Resistant Hiv-1 Therapeutic Targets
Dewdney, T. G. (2013) · Human Biology · Cited by 1
Meanwell, N. A., D’Andrea, S. V., Cianci, C., Dicker, I. B., Yeung, K., Belema, M., & Krystal, M. (2013) · Drug Discovery · doi:10.1002/9781118354483.ch11
Design and Discovery of Peptide‐Based HIV‐1 Integrase Inhibitors
Long, Y., & Neamati, N. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch24
Studies of Fv1 binding and restriction
Li, H. L. W. (2015) · UCL Discovery (University College London)
Structural aspects of Lentiviral Integrase–LEDGF Interaction
Hare, S., Engelman, A., & Cherepanov, P. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch10
Self-citation"Synthesis and Computational Studies on Hiv-1 Integrase Inhibitors"
Sharma, H. (2011) · doi:10.21007/etd.cghs.2011.0285 · Cited by 1
Metadata
- Authors
- Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P.
- Affiliations
- Imperial College London (GB)
- The University of Queensland (AU)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Cherepanov, Peter
- Venue
- Nature
- Published
- 2010-01-31
- Volume
- 464
- Issue
- 7286
- Pages
- 232-236
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2837123
- OpenAlex
- W2025344323
- Cited by
- 678
- References
- 50
- Citations by year
- 2026: 14 · 2025: 10 · 2024: 15 · 2023: 21 · 2022: 19 · 2021: 31 · 2020: 29 · 2019: 38 · 2018: 33 · 2017: 31 · 2016: 43 · 2015: 53 · 2014: 49 · 2013: 68 · 2012: 79
- FWCI
- 60.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Diamond Light Source
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (R01AI070042, P30AI060354)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- retroviral integrase, intasome, DNA strand transfer, HIV-1 integrase, integrase strand transfer inhibitors, raltegravir, elvitegravir, antiretroviral drug development, viral DNA integration, protein-DNA interactions
- MeSH terms
- DNA, Viral, Models, Molecular, Retroviridae, HIV-1, Protein Structure, Tertiary, Integrases, Catalytic Domain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.